Sept 18 (Reuters) - Briacell Therapeutics Corp BCT.V :
* BRIACELL THERAPEUTICS CORP FILES PROSPECTUS RELATED TO U.S. IPO OF 2.95 MILLION COMMON UNITS AND PRE-FUNDED UNITS THROUGH UNDERWRITERS
* BRIACELL THERAPEUTICS - IN PROCESS OF APPLYING TO LIST COMMON SHARES, WARRANTS ON NASDAQ CAPITAL MARKET UNDER SYMBOLS “BCTX” AND “BCTXW”, RESPECTIVELY
* BRIACELL THERAPEUTICS CORP - CURRENTLY ESTIMATED THAT IPO PRICE PER COMMON UNIT WILL BE BETWEEN US $4.13 AND US $5.13
* BRIACELL THERAPEUTICS CORP - CURRENTLY ESTIMATED THAT IPO PRICE PER PRE-FUNDED UNIT WILL BE BETWEEN US $4.12 AND US $5.12
* BRIACELL THERAPEUTICS CORP - IN ADDITION, HAVE REGISTERED AN AGGREGATE OF 50,000 COMMON SHARES FOR RESALE BY A CERTAIN SHAREHOLDER
* BRIACELL THERAPEUTICS CORP - OFFERING ALSO INCLUDES COMMON SHARES ISSUABLE FROM TIME TO TIME UPON EXERCISE OF PRE-FUNDED WARRANTS AND WARRANTS